Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Ziprasidone HCL (oral)
DRUG
2 trials
Sponsors
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions
Bipolar Disorder
Schizophrenia and Disorders With Psychotic Features
Phase 3
One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome
Terminated
NCT01113541
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Bipolar Disorder
Start: 2010-07-31
End: 2011-02-28
Updated: 2021-03-03
Phase 4
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
Terminated
NCT00748566
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Schizophrenia and Disorders With Psychotic Features
Start: 2008-12-31
End: 2012-05-31
Updated: 2021-03-03
Related Papers
The effect of ziprasidone on metabolic syndrome risk factors in subjects with schizophrenia: a 1 year, open-label, prospective study.
2014-03-17
3 citations